Carla A. Talarico - Search Results

Year	Number of Results
2017	1
2018	3
2021	4
2022	6
2023	3

1

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.

Tseng HF, Ackerson BK, Luo Y, Sy LS, Talarico CA, Tian Y, Bruxvoort KJ, Tubert JE, Florea A, Ku JH, Lee GS, Choi SK, Takhar HS, Aragones M, Qian L. Tseng HF, et al. Among authors: talarico ca. Nat Med. 2022 May;28(5):1063-1071. doi: 10.1038/s41591-022-01753-y. Epub 2022 Feb 21. Nat Med. 2022. PMID: 35189624 Free PMC article.

2

Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.

Tseng HF, Ackerson BK, Luo Y, Sy LS, Talarico CA, Tian Y, Bruxvoort KJ, Tubert JE, Florea A, Ku JH, Lee GS, Choi SK, Takhar HS, Aragones M, Qian L. Tseng HF, et al. Among authors: talarico ca. Nat Med. 2022 May;28(5):1095. doi: 10.1038/s41591-022-01818-y. Nat Med. 2022. PMID: 35449419 Free PMC article. No abstract available.

3

The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program.

Shiri T, Evans M, Talarico CA, Morgan AR, Mussad M, Buck PO, McEwan P, Strain WD. Shiri T, et al. Among authors: talarico ca. Vaccines (Basel). 2022 Jan 18;10(2):140. doi: 10.3390/vaccines10020140. Vaccines (Basel). 2022. PMID: 35214599 Free PMC article.

4

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study.

Bruxvoort KJ, Sy LS, Qian L, Ackerson BK, Luo Y, Lee GS, Tian Y, Florea A, Takhar HS, Tubert JE, Talarico CA, Tseng HF. Bruxvoort KJ, et al. Among authors: talarico ca. Lancet Reg Health Am. 2022 Feb;6:100134. doi: 10.1016/j.lana.2021.100134. Epub 2021 Nov 25. Lancet Reg Health Am. 2022. PMID: 34849505 Free PMC article.

5

Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study.

Florea A, Sy LS, Luo Y, Qian L, Bruxvoort KJ, Ackerson BK, Lee GS, Ku JH, Tubert JE, Tian Y, Talarico CA, Tseng HF. Florea A, et al. Among authors: talarico ca. PLoS One. 2022 Apr 28;17(4):e0267824. doi: 10.1371/journal.pone.0267824. eCollection 2022. PLoS One. 2022. PMID: 35482785 Free PMC article.

6

Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.

Malden DE, Bruxvoort KJ, Tseng HF, Ackerson B, Choi SK, Florea A, Tubert J, Takhar H, Aragones M, Hong V, Talarico CA, McLaughlin JM, Qian L, Tartof SY. Malden DE, et al. Among authors: talarico ca. MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1415-1419. doi: 10.15585/mmwr.mm7040a4. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34618801 Free PMC article.

7

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.

Tseng HF, Ackerson BK, Bruxvoort KJ, Sy LS, Tubert JE, Lee GS, Ku JH, Florea A, Luo Y, Qiu S, Choi SK, Takhar HS, Aragones M, Paila YD, Chavers S, Talarico CA, Qian L. Tseng HF, et al. Among authors: talarico ca. Nat Commun. 2023 Jan 12;14(1):189. doi: 10.1038/s41467-023-35815-7. Nat Commun. 2023. PMID: 36635284 Free PMC article.

8

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.

Bruxvoort KJ, Sy LS, Qian L, Ackerson BK, Luo Y, Lee GS, Tian Y, Florea A, Aragones M, Tubert JE, Takhar HS, Ku JH, Paila YD, Talarico CA, Tseng HF. Bruxvoort KJ, et al. Among authors: talarico ca. BMJ. 2021 Dec 15;375:e068848. doi: 10.1136/bmj-2021-068848. BMJ. 2021. PMID: 34911691 Free PMC article.

9

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults.

Florea A, Sy LS, Qian L, Ackerson BK, Luo Y, Tubert JE, Lee GS, Ku JH, Bruxvoort KJ, Talarico CA, Qiu S, Tian Y, Tseng HF. Florea A, et al. Among authors: talarico ca. Clin Infect Dis. 2023 Jan 13;76(2):252-262. doi: 10.1093/cid/ciac785. Clin Infect Dis. 2023. PMID: 36134518 Free PMC article.

10

Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example.

Shiri T, Evans M, Talarico CA, Morgan AR, Mussad M, Buck PO, McEwan P, Strain WD. Shiri T, et al. Among authors: talarico ca. Vaccines (Basel). 2021 Oct 15;9(10):1180. doi: 10.3390/vaccines9101180. Vaccines (Basel). 2021. PMID: 34696288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

15 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year